You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

List of Excipients in API citalopram


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing citalopram

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc CELEXA citalopram 0456-4010 CELLULOSE, MICROCRYSTALLINE
Allergan Inc CELEXA citalopram 0456-4010 COPOVIDONE K25-31
Allergan Inc CELEXA citalopram 0456-4010 CROSCARMELLOSE SODIUM
Allergan Inc CELEXA citalopram 0456-4010 FERRIC OXIDE RED
Allergan Inc CELEXA citalopram 0456-4010 FERRIC OXIDE YELLOW
Allergan Inc CELEXA citalopram 0456-4010 GLYCERIN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing citalopram

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc citalopram 0054-0062 METHYLPARABEN
Hikma Pharmaceuticals USA Inc citalopram 0054-0062 PEPPERMINT
Hikma Pharmaceuticals USA Inc citalopram 0054-0062 PROPYLENE GLYCOL
Hikma Pharmaceuticals USA Inc citalopram 0054-0062 PROPYLPARABEN
Hikma Pharmaceuticals USA Inc citalopram 0054-0062 SORBITOL
Hikma Pharmaceuticals USA Inc citalopram 0054-0062 WATER
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for citalopram

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77891

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

citalopram drug variants not containing MAGNESIUM STEARATE

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc citalopram 0054-0062
Chartwell RX LLC citalopram 62135-540
Pharmaceutical Associates Inc citalopram hydrobromide 0121-0848
Atlantic Biologicals Corps citalopram hydrobromide 17856-0540
ATLANTIC BIOLOGICALS CORP citalopram hydrobromide 17856-0564
Camber Pharmaceuticals Inc citalopram hydrobromide 31722-564
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: PEG-8

Excipient focus: PEPPERMINT

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

citalopram drug variants containing POLYETHYLENE GLYCOLS

Company Ingredient NDC
Aphena Pharma Solutions - New Jersey LLC citalopram 53401-200
State of Florida DOH Central Pharmacy citalopram 53808-0906
State of Florida DOH Central Pharmacy citalopram 53808-1077
DIRECT RX citalopram 61919-288
NCS HealthCare of KY Inc dba Vangard Labs citalopram hydrobromide 0615-7830
Rebel Distributors Corp citalopram hydrobromide 42254-116
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K12

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: VP/VA COPOLYMER

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links